PracticeVideosBlogFlashcardsEspañol
All Practice Exams

100+ Free QCHP/DHP Pharmacist Exam Practice Questions

Pass your QCHP/DHP Qualifying Examination - Pharmacist (CBT via Prometric) exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
100+ Questions
100% Free
1 / 100
Question 1
Score: 0/0

Which statement about the p-value in a clinical study is correct?

A
B
C
D
to track
Same family resources

Explore More Gulf Pharmacist Licensing Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

DHA Pharmacist Licensing Assessment

Practice Questions

DOH Abu Dhabi Pharmacist Qualification Exam

Practice Questions

Kuwait MOH Licensing Examination - Pharmacist

Practice Questions

MOHAP Pharmacist Evaluation Exam

Practice Questions

NHRA Licensure Examination - Pharmacist

Practice Questions

OMSB Licensing Examination - Pharmacist

Practice Questions

Sample QCHP/DHP Pharmacist Exam Practice Questions

Try these sample questions to test your QCHP/DHP Pharmacist Exam exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A pharmacist reviews a biochemistry concept for the DHP qualifying exam. Which enzyme catalyzes the rate-limiting step of cholesterol biosynthesis and is the molecular target of statin drugs?
A.HMG-CoA reductase
B.Squalene synthase
C.Acetyl-CoA carboxylase
D.Cholesterol 7-alpha-hydroxylase
Explanation: HMG-CoA reductase converts HMG-CoA to mevalonate, the rate-limiting and committed step of cholesterol synthesis. Statins competitively inhibit this enzyme, lowering hepatic cholesterol and upregulating LDL receptors. This is foundational biomedical science directly linked to therapeutics.
2Which of the following best describes a phase II (conjugation) reaction in hepatic drug metabolism?
A.Cytochrome P450-mediated oxidation of a drug
B.Hydrolysis of an ester bond by plasma esterases
C.Glucuronidation of a drug to increase its water solubility
D.Reduction of a nitro group to an amine
Explanation: Phase II reactions are conjugation reactions that attach an endogenous polar group (e.g., glucuronic acid, sulfate, glutathione) to a drug or its phase I metabolite, increasing water solubility for excretion. Glucuronidation by UGT enzymes is the classic example.
3A patient is deficient in glucose-6-phosphate dehydrogenase (G6PD). Administration of which drug is most likely to precipitate acute hemolytic anemia in this patient?
A.Acetaminophen (paracetamol)
B.Amoxicillin
C.Primaquine
D.Metformin
Explanation: G6PD generates NADPH needed to regenerate glutathione, which protects red cells from oxidative stress. Oxidant drugs such as primaquine, dapsone, sulfonamides, and nitrofurantoin can trigger acute hemolysis in G6PD-deficient patients. This links a biomedical enzyme defect to a clinical drug-safety decision.
4Which immunoglobulin class is the predominant antibody in secretions such as saliva, tears, and breast milk, providing mucosal immunity?
A.IgG
B.IgM
C.IgA
D.IgE
Explanation: Secretory IgA is the dominant immunoglobulin at mucosal surfaces and in exocrine secretions, where it neutralizes pathogens and toxins. Understanding immunoglobulin function supports topics such as vaccines and biologic therapy in the biomedical sciences domain.
5A drug acts as a competitive antagonist at a receptor. What is the expected effect on the agonist dose-response curve?
A.The curve shifts to the right with no change in maximal effect
B.The curve shifts to the left with increased potency
C.The maximal effect is reduced and cannot be overcome
D.The curve becomes steeper with no change in EC50
Explanation: A competitive (reversible) antagonist binds the same site as the agonist and shifts the agonist dose-response curve to the right (decreased apparent potency, increased EC50) without lowering the maximal response, because the antagonism can be overcome by higher agonist concentrations.
6Which of the following correctly describes the physiological role of the renin-angiotensin-aldosterone system (RAAS)?
A.It lowers blood pressure by promoting vasodilation and sodium loss
B.Aldosterone promotes potassium retention and sodium excretion
C.Renin directly converts angiotensin I to angiotensin II
D.Angiotensin II causes vasoconstriction and stimulates aldosterone release
Explanation: Angiotensin II is a potent vasoconstrictor that also stimulates the adrenal cortex to release aldosterone, increasing sodium and water retention and raising blood pressure. This physiology underlies ACE inhibitors, ARBs, and aldosterone antagonists used in hypertension and heart failure.
7Bacterial resistance to beta-lactam antibiotics most commonly arises through which mechanism?
A.Production of beta-lactamase enzymes that hydrolyze the beta-lactam ring
B.Active efflux of aminoglycosides from the cell
C.Methylation of the 23S ribosomal RNA
D.Mutation of DNA gyrase reducing fluoroquinolone binding
Explanation: The most common mechanism of beta-lactam resistance is enzymatic destruction by beta-lactamases (including extended-spectrum and carbapenemase variants) that cleave the beta-lactam ring. Beta-lactamase inhibitors such as clavulanic acid are combined with penicillins to counter this.
8Which neurotransmitter is primarily deficient in the nigrostriatal pathway in Parkinson's disease?
A.Acetylcholine
B.Serotonin
C.Dopamine
D.Gamma-aminobutyric acid (GABA)
Explanation: Parkinson's disease results from degeneration of dopaminergic neurons in the substantia nigra, reducing dopamine in the nigrostriatal pathway. This underlies the use of levodopa, dopamine agonists, and MAO-B inhibitors to restore dopaminergic tone.
9A genetic polymorphism reduces a patient's CYP2C19 activity (poor metabolizer). Which commonly prescribed antiplatelet drug is most likely to have reduced efficacy in this patient?
A.Aspirin
B.Clopidogrel
C.Ticagrelor
D.Dipyridamole
Explanation: Clopidogrel is a prodrug requiring CYP2C19-mediated bioactivation to its active metabolite. CYP2C19 poor metabolizers form less active drug and have reduced platelet inhibition and higher cardiovascular event risk, an important pharmacogenomics concept.
10Which of the following is the principal buffer system maintaining blood pH within the physiological range of 7.35-7.45?
A.Phosphate buffer system
B.Protein (hemoglobin) buffer system only
C.Bicarbonate-carbonic acid buffer system
D.Ammonia buffer system
Explanation: The bicarbonate-carbonic acid system is the most important extracellular buffer for blood pH because both components are physiologically regulated: CO2 by the lungs and bicarbonate by the kidneys. This underpins the interpretation of acid-base disorders.

About the QCHP/DHP Pharmacist Exam Exam

The pharmacist qualifying examination is a computer-based Prometric test (exam code SCHQ2) required by Qatar's Department of Healthcare Professions for pharmacist licensure. The official blueprint specifies 150 MCQs in 3.5 hours with a 60% pass mark, distributed across basic biomedical, pharmaceutical, social/behavioral/administrative, and clinical sciences. Pharmacist exam content was updated effective 1 May 2025 with a revised reference list.

Assessment

150 single-best-answer MCQs across four content areas: Basic Biomedical Sciences (15), Pharmaceutical Sciences (53), Social/Behavioral/Administrative Sciences (30), and Clinical Sciences (52).

Time Limit

3.5 hours per the official pharmacist blueprint (the DHP summary table lists 3 hours; confirm current timing on the DHP site).

Passing Score

60% cut score (90 of 150 correct), per the official DHP MOPH qualifying examination table.

Exam Fee

Approximately USD 238 in 2024-2025 with an announced increase from 1 January 2026 (reported figures vary, around USD 244-285); confirm the current Prometric fee for exam code SCHQ2. (Qatar Department of Healthcare Professions (DHP), MOPH (formerly QCHP))

QCHP/DHP Pharmacist Exam Exam Content Outline

10%

Basic Biomedical Sciences

Biochemistry, physiology, immunology, microbiology, core pharmacology, and pharmacogenomics that underpin drug action (15 of 150 official items).

35%

Pharmaceutical Sciences

Dosage-form design, pharmacy calculations and compounding, biopharmaceutics, pharmacokinetics, sterilization, and drug stability (53 of 150 official items).

20%

Social, Behavioral and Administrative Sciences

Pharmacy management, pharmacoeconomics, biostatistics and drug-literature evaluation, ethics, communication, and Qatar pharmacy law and regulation (30 of 150 official items).

35%

Clinical Sciences

Pharmacotherapy and disease-state management, drug interactions, therapeutic drug monitoring, special populations, toxicology, and counseling (52 of 150 official items).

How to Pass the QCHP/DHP Pharmacist Exam Exam

What You Need to Know

  • Passing score: 60% cut score (90 of 150 correct), per the official DHP MOPH qualifying examination table.
  • Assessment: 150 single-best-answer MCQs across four content areas: Basic Biomedical Sciences (15), Pharmaceutical Sciences (53), Social/Behavioral/Administrative Sciences (30), and Clinical Sciences (52).
  • Time limit: 3.5 hours per the official pharmacist blueprint (the DHP summary table lists 3 hours; confirm current timing on the DHP site).
  • Exam fee: Approximately USD 238 in 2024-2025 with an announced increase from 1 January 2026 (reported figures vary, around USD 244-285); confirm the current Prometric fee for exam code SCHQ2.

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

QCHP/DHP Pharmacist Exam Study Tips from Top Performers

1Weight your study time to the blueprint: Pharmaceutical Sciences and Clinical Sciences each carry about 35% of the exam, so prioritize pharmacy calculations, pharmacokinetics, pharmacotherapy, and drug interactions.
2Drill pharmacy calculations (dilutions, alligation, ratio strength, IV rates, weight-based pediatric dosing) until they are fast and automatic, since they appear throughout the Pharmaceutical Sciences domain.
3Review the current DHP reference list (updated 1 May 2025) and Qatar-specific pharmacy law, controlled-drug handling, ethics, and pharmacovigilance reporting for the Social/Behavioral/Administrative domain.

Frequently Asked Questions

How many questions are on the QCHP/DHP pharmacist exam and how long is it?

The official DHP MOPH pharmacist blueprint specifies 150 multiple-choice questions in 3.5 hours. The DHP qualifying-exam summary table lists 3 hours, so confirm current timing on the official DHP site before your exam.

What is the passing score for the Qatar pharmacist qualifying exam?

The cut score is 60%, equivalent to 90 of 150 correct answers, per the official DHP MOPH qualifying examination table.

Which content areas does the pharmacist exam cover?

Four areas: Basic Biomedical Sciences (15 items), Pharmaceutical Sciences (53 items), Social/Behavioral/Administrative Sciences (30 items), and Clinical Sciences (52 items), totaling 150 items.

Who administers the exam and what is the Prometric code?

The Department of Healthcare Professions (DHP) under Qatar's Ministry of Public Health (MOPH), formerly the Qatar Council for Healthcare Practitioners (QCHP), sets the content. It is delivered as a computer-based test by Prometric under exam code SCHQ2. Pharmacist content was updated effective 1 May 2025.